Enzolytics (ENZC) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 115 252 sessions, November 13, 2025 to November 13, 2026
- Largest daily move
- +100% close of December 26, 2025
- 1-year change
- +33.3% closing prices, November 13, 2025 to November 13, 2026
- 1-month change
- -20% closing prices, October 13, 2026 to November 13, 2026
Company Description
Enzolytics (OTC: ENZC) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.9M.
ENZC has gained 33.3% over the past year. The last closing price was $0.0004.
This page collects what Stock Titan holds for ENZC, including price data, latest news, and short interest trends.
Stock Performance
Enzolytics (ENZC) closed at $0.0004 on November 13, 2026. Over the past 12 months, the price has gained 33.3%.
ENZC Metrics & Rankings
Price returns through November 13, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Enzolytics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, partnership. View all ENZC news →
SEC Filings
Short Interest History
Short interest in Enzolytics (ENZC) currently stands at 259 shares. Since November 2025, short interest has increased by 23.9%.
Days to Cover History
Days to cover for Enzolytics (ENZC) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
ENZC Company Profile & Sector Positioning
Enzolytics (ENZC) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ENZC often look at related companies in the same sector, including AccuStem Sciences Inc (ACUT), CASI Pharmaceuticals Inc (CASIF), Emmaus Life Sciences Inc (EMMA), Grey Matters Health Inc (AGNPF), and LIR Life Sciences Corp (BBCMF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ENZC's relative position within its industry.